Chia-Feng Tsai

Chia-Feng Tsai is a Senior Scientist at Scorpion Therapeutics since March 2023, focusing on the development of a DIA workflow for ABPP analysis. Prior to this role, Chia-Feng held the position of Biomedical Scientist at Pacific Northwest National Laboratory from November 2017 to March 2023, where contributions included method development for single-cell proteome. Chia-Feng's experience also includes multiple postdoctoral research fellowships at renowned institutions such as Kyoto University, Academia Sinica in Taiwan, and the Max Planck Institute of Biochemistry between 2014 and 2017, along with a research assistant role at Academia Sinica from 2007 to 2010. Chia-Feng earned a Doctor of Philosophy (Ph.D.) in Analytical Chemistry from National Taiwan University, a Master's degree in Analytical Chemistry from National Taiwan Normal University, and a Bachelor's degree in Chemistry from Tamkang University.